agilon health (NYSE:AGL) Earns Hold Rating from Analysts at Needham & Company LLC

Needham & Company LLC initiated coverage on shares of agilon health (NYSE:AGL - Free Report) in a report issued on Friday, MarketBeat.com reports. The brokerage issued a hold rating on the stock.

Several other brokerages have also recently issued reports on AGL. Royal Bank of Canada reiterated an "outperform" rating and set a $3.00 price target on shares of agilon health in a research report on Tuesday, November 19th. Barclays cut their price objective on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a report on Monday, November 11th. Sanford C. Bernstein initiated coverage on shares of agilon health in a report on Wednesday, December 11th. They issued a "market perform" rating and a $2.50 price objective on the stock. Macquarie initiated coverage on shares of agilon health in a report on Monday, December 16th. They issued a "neutral" rating and a $3.00 price objective on the stock. Finally, Bank of America cut shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $3.98.

agilon health Trading Up 10.5 %

Shares of NYSE:AGL traded up $0.23 during midday trading on Friday, hitting $2.42. 6,908,048 shares of the stock traded hands, compared to its average volume of 3,722,896. The stock has a market capitalization of $997.08 million, a PE ratio of -2.57 and a beta of 0.53. The business's 50 day moving average is $2.07 and its two-hundred day moving average is $3.77. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a one year low of $1.50 and a one year high of $8.20.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period last year, the company posted ($0.06) earnings per share. As a group, research analysts forecast that agilon health will post -0.52 earnings per share for the current year.

Insider Activity at agilon health

In related news, Director Karen Mcloughlin purchased 25,000 shares of agilon health stock in a transaction on Friday, December 13th. The shares were bought at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 90,000 shares of company stock worth $198,100 over the last quarter. Company insiders own 3.20% of the company's stock.

Institutional Trading of agilon health

A number of large investors have recently made changes to their positions in the business. JPMorgan Chase & Co. increased its holdings in shares of agilon health by 326.4% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock worth $5,563,000 after buying an additional 1,083,492 shares during the last quarter. Virtu Financial LLC bought a new stake in shares of agilon health in the 3rd quarter worth about $120,000. Geode Capital Management LLC grew its holdings in agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock valued at $27,097,000 after purchasing an additional 84,889 shares during the last quarter. Barclays PLC grew its holdings in agilon health by 21.2% during the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company's stock valued at $4,830,000 after purchasing an additional 214,830 shares during the last quarter. Finally, XTX Topco Ltd grew its holdings in agilon health by 271.1% during the 3rd quarter. XTX Topco Ltd now owns 119,747 shares of the company's stock valued at $471,000 after purchasing an additional 87,481 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.